These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19652769)

  • 41. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?
    Budney AJ
    Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can tobacco dependence provide insights into other drug addictions?
    DiFranza JR
    BMC Psychiatry; 2016 Oct; 16(1):365. PubMed ID: 27784294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
    D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
    Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical dependence on diazepam and lorazepam in the dog.
    McNicholas LF; Martin WR; Cherian S
    J Pharmacol Exp Ther; 1983 Sep; 226(3):783-9. PubMed ID: 6136601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Physical dependence on benzodiazepines in traumatology].
    Berezak A; Weber M; Hansmann J; Tulasne PA; Laporte B; Ould Ouali A
    Ann Fr Anesth Reanim; 1984; 3(5):383-4. PubMed ID: 6149713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
    McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
    J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations.
    Strain EC; Mumford GK; Silverman K; Griffiths RR
    JAMA; 1994 Oct; 272(13):1043-8. PubMed ID: 8089887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigating correlates of synthetic marijuana and Salvia use in light and intermittent smokers and college students in a predominantly Hispanic sample.
    Gutierrez KM; Cooper TV
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):524-9. PubMed ID: 25285845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.
    Mikulich SK; Hall SK; Whitmore EA; Crowley TJ
    Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers.
    Hesse M; Thylstrup B
    BMC Psychiatry; 2013 Oct; 13():258. PubMed ID: 24118963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis Withdrawal - A New Diagnostic Category in DSM-5.
    Katz G; Lobel T; Tetelbaum A; Raskin S
    Isr J Psychiatry Relat Sci; 2014; 51(4):270-5. PubMed ID: 25841223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.
    Shmulewitz D; Greene ER; Hasin D
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1878-900. PubMed ID: 26332166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Internet highs--seizures after consumption of synthetic cannabinoids purchased online.
    Tofighi B; Lee JD
    J Addict Med; 2012 Sep; 6(3):240-1. PubMed ID: 22824736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
    Vo KT; Horng H; Smollin CG; Benowitz NL
    J Emerg Med; 2017 May; 52(5):680-683. PubMed ID: 27979642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should tolerance and withdrawal be required for substance dependence disorders?
    Carroll KM; Rounsaville BJ; Bryant KJ
    Drug Alcohol Depend; 1994 Aug; 36(1):15-22. PubMed ID: 7988354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.